Dr. Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research. He is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.
Merz A, Mohamed A, Corbett C, Herring K, Hildenbrand J, Locke SC, et al. A single-site pilot feasibility randomized trial of a supportive care mobile application intervention for patients with advanced cancer and caregivers. Support Care Cancer. 2022 Oct;30(10):7853–61.
Patierno BM, Foo W-C, Allen T, Somarelli JA, Ware KE, Gupta S, et al. Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. In: Prostate Cancer Prostatic Dis. 2022. p. 513–23.
Zhang S, Mao M, Lv Y, Yang Y, He W, Song Y, et al. A widespread length-dependent splicing dysregulation in cancer. Sci Adv. 2022 Aug 19;8(33):eabn9232.